Regeneron Pharmaceuticals, Inc. logo REGN - Regeneron Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 34
HOLD 15
SELL 0
STRONG
SELL
0
| PRICE TARGET: $827.71 DETAILS
HIGH: $1,030.00
LOW: $730.00
MEDIAN: $824.00
CONSENSUS: $827.71
UPSIDE: 5.91%
AlphaQuality

AlphaQuality

Quantitative six-pillar business-quality grade

Platform & Compounding FCF

AlphaQuality — archetype-weighted quantitative grade

B+ 79.0 / 100 composite

Composite Grade

Composite of six pillars weighted for platform & compounding fcf businesses. Purely quantitative — the six pillars score only reported financials, no analyst input.

Profitability

Weight: 25%
B- 62.2
  • 5yr Avg ROIC 18.7% 89/100
  • Operating Margin Trend -7.76 pp/yr 0/100
Contributes 15.6 pts toward composite.

Capital Efficiency

Weight: 15%
A 89.6
  • 5yr Avg ROE 21.4% 94/100
  • 5yr Share-Count CAGR -1.2% 81/100
Contributes 13.4 pts toward composite.

Growth Quality

Weight: 25%
B 74.7
  • 5yr Revenue CAGR 11.0% 83/100
  • 5yr EPS CAGR 6.3% 62/100
  • Revenue-Growth Years (5) 4/5 80/100
Contributes 18.7 pts toward composite.

Cash Generation

Weight: 20%
A+ 95.4
  • 5yr FCF Margin 31.8% 100/100
  • 5yr FCF/NI Conversion 0.90x 90/100
Contributes 19.1 pts toward composite.

Balance Sheet

Weight: 10%
A+ 100.0
  • Net Debt / EBITDA -1.01x 100/100
  • Interest Coverage (EBIT/Int) 120.42x 100/100
  • Altman Z-Score 7.62 100/100
Contributes 10.0 pts toward composite.

Stability

Weight: 5%
C- 44.2
  • EPS Volatility (σ/μ) 0.67 17/100
  • Negative-Revenue Years (5) 1/5 80/100
  • Piotroski F-Score 5 56/100
Contributes 2.2 pts toward composite.

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Accumulating

4 of 4 gurus held; 3 added; 1 trimmed.

Holders
4
Avg Δ position
+30.7%
New buys
0
Full exits
0
As of Q2 2026
How this is calculated

AlphaQuality grades six pillars from 0-100 and weights each by archetype:

  • Profitability (25%) — 5yr Avg ROIC, Operating Margin Trend
  • Capital Efficiency (15%) — 5yr Avg ROE, 5yr Share-Count CAGR
  • Growth Quality (25%) — 5yr Revenue CAGR, 5yr EPS CAGR, Revenue-Growth Years (5)
  • Cash Generation (20%) — 5yr FCF Margin, 5yr FCF/NI Conversion
  • Balance Sheet (10%) — Net Debt / EBITDA, Interest Coverage (EBIT/Int), Altman Z-Score
  • Stability (5%) — EPS Volatility (σ/μ), Negative-Revenue Years (5), Piotroski F-Score

The six pillars read only reported financial-statement fields — no analyst targets or consensus ratings. The archetype that picks which pillar formulas apply is not fully price-free, though: it can route a company to the distressed/ungradable archetype based on price vs. its 52-week high, and beta affects one classification check. A minimum of 5 fiscal years of audited statements is required. Insurers and banks are graded on their own methodology — insurers on loss ratio, its trend and stability, and premiums-to-surplus; banks on the efficiency ratio, its trend and stability, and equity-to-assets — rather than on industrial margin/ROIC signals. Distressed, highly leveraged infrastructure, asset-manager, and other financial businesses are declared ungradable rather than forced into a numeric score.